Prostate cancer mortality statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Deaths

Deaths from prostate cancer, 2015-2017, UK.

Proportion of all deaths

Percentage prostate cancer contributes to total cancer deaths, 2015-2017, UK

Age

Peak rate of prostate cancer deaths, 2015-2017, UK

 

Trend over time

Change in prostate cancer mortality rates since the early 1970s, Males, UK

Prostate cancer is the 2nd most common cause of cancer death in males in the UK, accounting for 14% of all cancer deaths in males (2017). In females and males combined, prostate cancer is the 3rd most common cause of cancer death in the UK, accounting for 7% of cancer deaths (2017).[1-3]

Prostate cancer mortality rates (European age-standardised (AS) rates) Open a glossary item are similar to the UK average in all the UK constituent countries.

Prostate Cancer (C61), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK, 2017

  England Scotland Wales Northern Ireland UK
Male Deaths 10,146 986 605 295 12,032
Crude Rate 36.9 37.3 39.3 32.1 36.9
AS Rate 47.7 49.0 45.9 49.1 47.8
AS Rate - 95% LCL 46.8 46.0 42.2 43.5 46.9
AS Rate - 95% UCL 48.6 52.1 49.5 54.6 48.6
Persons Deaths 10,146 986 605 295 12,032
Crude Rate 18.2 18.2 19.4 15.8 18.2
AS Rate 19.5 19.4 18.6 19.4 19.5
AS Rate - 95% LCL 19.1 18.2 17.1 17.2 19.1
AS Rate - 95% UCL 19.9 20.7 20.0 21.6 19.8

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

See also

Prostate cancer incidence statistics by UK region

Prostate cancer survival statistics

Cancer mortality statistics for common cancers in the UK

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C61.

Last reviewed:

Prostate cancer mortality is strongly related to age, with the highest mortality rates being in older men. In the UK in 2015-2017, on average each year around three-quarters (74%) of deaths were in males aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for prostate cancer in older people.

Age-specific mortality rates rise steeply from around age 55-59. The highest rates are in the 90+ age group. 

Prostate Cancer (C61), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Male Population, UK, 2015-2017

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

See also

Prostate cancer incidence statistics by age

Prostate cancer survival statistics by age

Cancer mortality statistics by age for all cancers

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, ICD-10 C61.

Last reviewed:

Prostate cancer European age-standardised (AS) Open a glossary item mortality rates for males increased by 18% in the UK between 1971-1973 and 2015-2017.[1-3].

Over the last decade in the UK (between 2005-2007 and 2015-2017), prostate cancer AS mortality rates for males decreased by 10%.[1-3]

Prostate Cancer (C61), European Age-Standardised Mortality Rates per 100,000 Population, Males, UK, 1971-2017

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Prostate cancer mortality rates have remained stable overall in some broad adult age groups in males in the UK since the early 1970s, but have increased or decreased in others.[1-3] Rates in 25-49s have remained stable, in 50-59s have remained stable, in 60-69s have remained stable, in 70-79s have decreased by 11%, and in 80+s have increased by 45%.

Prostate Cancer (C61), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Males, UK, 1971-2017

See also

Prostate cancer incidence trends over time

Prostate cancer survival trends over time

Prostate cancer risk factors

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2017, C61.

Last reviewed:

Prostate cancer mortality rates are projected to fall by 16% in the UK between 2014 and 2035, to 48 deaths per 100,000 males by 2035.[1]

Prostate cancer (C61), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

Download the data table (xls)

It is projected that 18,336 deaths from prostate cancer will occur in the UK in 2035.

See also

Find out how these projections were calculated

Mortality trends over time for prostate cancer

Projections of mortality for all cancers combined

Download the projections data table

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C61

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is no evidence for an association between prostate cancer mortality and deprivation in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are similar for males living in the most deprived areas compared with the least deprived.[1]

Prostate Cancer (C61), European Age-Standardised Mortality Rates by Deprivation Quintile, Males, England, 2007-2011

The estimated deprivation gradient in prostate cancer mortality between males living in the most and the least deprived areas in England has not changed in the period 2002-2011.[1]

See also

Find out more about the definitions and evidence for this data

Deprivation gradient for cancer mortality

Deprivation gradient in prostate cancer incidence

Socio-economic variation in cancer mortality for Scotland

Socio-economic variation in cancer mortality for Wales

Socio-economic variation in cancer mortality for Northern Ireland

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation  in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C61

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

 @CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.